Value-Based Healthcare and Payment Innovation

In an era of rising healthcare costs, sustainably paying for high-quality health services and cutting-edge medicines and technologies is a critical issue. This is particularly true in the United States as it continues to shift from a volume- to value-based paradigm.  

Tapestry works with leaders to address the challenges of whole-system financing and value-based reimbursement. Our initiatives have explored payment approaches for transformative treatments like cell and gene therapy and for healthcare provision in complex medical specialties.

Recent projects include: 

• The Inflammatory Bowel Disease (IBD) Shared Value Initiative: Advancing value in specialized remains a significant challenge. In this effort, Tapestry is engaging clinicians, payers, and other stakeholders to create a safe forum for candid dialogue around value-based care in IBD, a complex disease area with variable costs and outcomes. Learn more.

• The Optimal Oncology Alternative Payment Models Advisory Council:  Tapestry worked with leading clinicians, payers, patient advocates, and industry actors to build a platform for assessing pilot APMs and advancing value-based cancer care. The Council produced analysis and insights including lessons from commercial payer pilot programs (as published in the American Journal of Managed Care).

• The Innovative Healthcare Financing (IHF) Working Group: Tapestry collaborated with the MIT Laboratory for Financial Engineering and Dana-Farber Cancer Institute to create a working group on sustainable payment for transformative oncology treatments. Participants considered how approaches from financial services could be adapted to help patients and payers better manage these treatments’ costs. Learn more.